Subscribe by Email

About the Blog

The Active Ingredient features expert insights and commentary from leaders of ZS Associates' global pharmaceuticals practice.

Search by Topic

see all

AI Will Usher in ‘Dramatic’ Changes to Pharma’s Commercial Model

Posted by Pratap Khedkar on Thu, Jan 18, 2018

This is the second post in a three-part series on artificial intelligence in healthcare. 

Artificial intelligence is poised to revolutionize the healthcare ecosystem. Providers are starting to apply AI in an effort to leverage patient data, therapy information and standards of care to make better treatment decisions. Payers are experimenting with AI to help with pre-authorization and claims adjudication. Whether or not the pharma industry is ready, AI is changing the way that pharma’s customers and stakeholders do business, thereby necessitating changes to pharma’s own commercial practices. And, according to my colleague John Piccone, those changes will be “dramatic.”

Read More

Topics: Big Pharma, healthcare ecosystem, AI, commercial strategy, artificial intelligence & pharma, pre-authorization, educate algorithms, treatment decisions, clinical decision support, claims, AI blog series

Subscribe to The Active Ingredient


Subscribe to receive email notifications whenever new blog posts are published.